[1] Scholl C, Gilliland DG, Frohling S. Deregulation of signaling pathways in acute myeloid leukemia. [J]. Seminars in Oncology 2008, 4(4). [2] Ihle NT, Powis G. Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy. [J]. Molecular cancer therapeutics 2009, 1(1). [3] Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar Uniyal M. [J]. Anticancer Research: International Journal of Cancer Research and Treatment 2006. [4] Weng LP, Brown JL, Eng C. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. [J]. Human Molecular Genetics 2001, 6(6). [5] Lee SJ, Yang EK, Kim SG. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. [J]. Molecular pharmacology 2006, 1(1). [6] Li, H.-F., Keeton, A., Vitolo, M., Maddox, C., Rasmussen, L., Hobrath, J., Lucille White, E., Ben Ho Park, Piazza, G.A., Kim, J.-S., Waldman, T.. [J]. Journal of biomolecular screening: The official journal of the Society for Biomolecular Screening 2011. [7] Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. [J]. Cancer research: The official organ of the American Association for Cancer Research, Inc 2008, 5(5). |